{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:33:31Z","timestamp":1783971211792,"version":"3.55.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s40256-018-0286-z","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:58:32Z","timestamp":1529629112000},"page":"361-372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Acute Coronary Syndrome in Cancer Patients"],"prefix":"10.1007","volume":"18","author":[{"given":"Begum","family":"Yetis Sayin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Ali","family":"Oto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"issue":"4","key":"286_CR1","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3322\/caac.21149","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics. Cancer J Clin. 2012;62(4):220\u201341.","journal-title":"Cancer J Clin."},{"key":"286_CR2","unstructured":"Expected New Cancer Cases and Deaths in 2020 (CDC website). 2016. http:\/\/www.cdc.gov\/cancer\/dcpc\/research\/articles\/cancer_2020.htm . Accessed 29 Nov 2016."},{"key":"286_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3322\/caac.21235","volume":"64","author":"CE Desantis","year":"2014","unstructured":"Desantis CE, Lin CC, Mariotto AB, et al. Cancer Treatment and Survivorship Statistics. CA Cancer J Clin. 2014;64:252\u201371.","journal-title":"CA Cancer J Clin"},{"issue":"25","key":"286_CR4","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1016\/j.jacc.2015.04.059","volume":"65","author":"A Barac","year":"2015","unstructured":"Barac A, Murtagh G, Carver JR, et al. Cardiovascular health of patients with cancer and cancer survivors: aroadmap to the next level. J Am Coll Cardiol. 2015;65(25):2739\u201346.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"286_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11936-017-0535-5","volume":"19","author":"DE Giza","year":"2017","unstructured":"Giza DE, Fernando B, Juan LM, Gloria I, et al. Ischemic heart disease: special considerations in cardio-oncology. Curr Treat Options Cardio Med. 2017;19(5):37.","journal-title":"Curr Treat Options Cardio Med."},{"issue":"7","key":"286_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.115.001779","volume":"4","author":"CN Hess","year":"2015","unstructured":"Hess CN, Roe MT, Clare RM, et al. Relationship between cancer and cardiovascular outcomes following percutaneous coronary intervention. J Am Heart Assoc. 2015;4(7):1\u20139.","journal-title":"J Am Heart Assoc"},{"key":"286_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","volume":"15","author":"R Angelis De","year":"2014","unstructured":"De Angelis R, Sant M, Coleman MP, EUROCARE-5 Working Group, et al. Cancer survival in Europe 1999\u20132007 by country and age: results of EUROCARE-5\u2014a populationbased study. Lancet Oncol. 2014;15:23\u201334.","journal-title":"Lancet Oncol"},{"issue":"10","key":"286_CR8","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.jacc.2013.09.058","volume":"63","author":"A Barac","year":"2014","unstructured":"Barac A. Yet another player in the cardio-oncology conundrum? J Am Coll Cardiol. 2014;63(10):1020\u20131. https:\/\/doi.org\/10.1016\/j.jacc.2013.09.058 .","journal-title":"J Am Coll Cardiol"},{"key":"286_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11886-017-0862-x","volume":"19","author":"DE Giza","year":"2017","unstructured":"Giza DE, Kostas M, Elie M, et al. Management of CAD in patients with active cancer: the Interventional cardiologists\u2019 perspective. Curr Cardiol Rep. 2017;19:56. https:\/\/doi.org\/10.1007\/s11886-017-0862-x .","journal-title":"Curr Cardiol Rep"},{"issue":"7","key":"286_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.tcm.2014.07.003","volume":"24","author":"J Herrmann","year":"2014","unstructured":"Herrmann J, Lerman A. An update on cardio-oncology. Trends Cardiovasc Med. 2014;24(7):285\u201395.","journal-title":"Trends Cardiovasc Med"},{"key":"286_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cam4.283","volume":"3","author":"NC Onwudiwe","year":"2014","unstructured":"Onwudiwe NC, Kwok Y, Onukwugha E, et al. Cardiovascular event-free survival after adjuvant radiation therapy in breast cancer patients stratified by cardiovascular risk. Cancer Med. 2014;3:1\u201311.","journal-title":"Cancer Med"},{"issue":"1","key":"286_CR12","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1016\/S0049-3848(16)30109-8","volume":"140","author":"T Svilaas","year":"2016","unstructured":"Svilaas T, Joop DL, Jourik AG, et al. Long-Term arterial complications of chemotherapy in patients with cancer. Thromb Res. 2016;140(1):S109\u201318.","journal-title":"Thromb Res"},{"key":"286_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/ccd.26379","volume":"87","author":"CA Iliescu","year":"2016","unstructured":"Iliescu CA, Grines CL, Herrmann J, et al. SCAI Expert consensus statement:evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiolog\u0131a intervencionista). Cathet Cardiovasc Intervent. 2016;87:202\u201323. https:\/\/doi.org\/10.1002\/ccd.26379 .","journal-title":"Cathet Cardiovasc Intervent"},{"issue":"24","key":"286_CR14","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","volume":"53","author":"ET Yeh","year":"2009","unstructured":"Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol. 2009;53(24):2231\u201347.","journal-title":"J Am Coll Cardiol"},{"key":"286_CR15","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.115.018347","volume":"133","author":"J Herrmann","year":"2016","unstructured":"Herrmann J, Yang EH, Il\u0131escu CA, et al. Vascular toxicities of cancer therapies. Circulation. 2016;133:1272\u201389.","journal-title":"Circulation"},{"issue":"1","key":"286_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1179\/joc.2003.15.1.89","volume":"15","author":"S Oliva","year":"2003","unstructured":"Oliva S, Mannarini A, Giotta F, et al. Prinzmetal\u2019s Variant Angina during cisdiamminodichloroplatinum (CDDP) administration: case report. J Chemother. 2003;15(1):89\u201390.","journal-title":"J Chemother"},{"issue":"3","key":"286_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/000331970605700314","volume":"57","author":"FM Bdair","year":"2006","unstructured":"Bdair FM, Graham SP, Smith PF, Javle MM. Gemcitabine and acute myocardial infarction\u2014a case report. Angiology. 2006;57(3):367\u201371.","journal-title":"Angiology"},{"issue":"1","key":"286_CR18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.32635\/2176-9745.RBC.2009v55n1.1677","volume":"55","author":"CE Paiva","year":"2009","unstructured":"Paiva CE, Michelin OC, Okoshi K. Acute coronary syndrome during chemotherapy: report of three cases. Rev Bra Cancerol. 2009;55(1):55\u20138.","journal-title":"Rev Bra Cancerol"},{"key":"286_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/ctrv.1999.0097","volume":"25","author":"H Lajer","year":"1999","unstructured":"Lajer H, Daugaard G. Cisplatin and hypomagnesemia. Cancer Treat Rev. 1999;25:47\u201358.","journal-title":"Cancer Treat Rev"},{"key":"286_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1126\/science.7361117","volume":"208","author":"PD Turlapaty","year":"1980","unstructured":"Turlapaty PD, Altura BM. Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science. 1980;208:198\u2013200.","journal-title":"Science"},{"key":"286_CR21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jjcc.2009.03.009","volume":"54","author":"Y Arima","year":"2009","unstructured":"Arima Y, Oshima S, Noda K, et al. Sorafenib-induced acute myocardial infarction due to coronary artery spasm. J Cardiol. 2009;54:512\u20135. https:\/\/doi.org\/10.1016\/j.jjcc.2009.03.009 .","journal-title":"J Cardiol"},{"issue":"4","key":"286_CR22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s00059-011-3444-5","volume":"36","author":"T Naib","year":"2011","unstructured":"Naib T, Steingart RM, Chen CL. Sorafenib-associated multivessel coronary artery vasospasm. Herz. 2011;36(4):348\u201351.","journal-title":"Herz."},{"issue":"3","key":"286_CR23","first-page":"775","volume":"18","author":"F Sen","year":"2013","unstructured":"Sen F, Yildiz I, Basaran M, et al. Impaired coronary flow reserve in metastatic cancer patients treated with sunitinib. J BUON Off J Balkan Union Oncol. 2013;18(3):775\u201381.","journal-title":"J BUON Off J Balkan Union Oncol"},{"key":"286_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/1471-2407-12-231","volume":"12","author":"MA Pantaleo","year":"2012","unstructured":"Pantaleo MA, Mandrioli A, Saponara M, et al. Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib. BMC Cancer. 2012;12:231. https:\/\/doi.org\/10.1186\/1471-2407-12-231 .","journal-title":"BMC Cancer."},{"key":"286_CR25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/ctrv.2000.0175","volume":"26","author":"MT Meinardi","year":"2000","unstructured":"Meinardi MT, Gietema JA, van Veldhuisen DJ, et al. Long-term chemotherapy-related cardiovascular morbidity. Cancer Treat Rev. 2000;26:429\u201347.","journal-title":"Cancer Treat Rev"},{"key":"286_CR26","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/eurheartj\/ehs181","volume":"34","author":"TM Suter","year":"2013","unstructured":"Suter TM, Ewer MS. Cancer drugs and the heart: importance and management. Eur Heart J. 2013;34:1102\u201311.","journal-title":"Eur Heart J"},{"key":"286_CR27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.4070\/kcj.2012.42.7.487","volume":"42","author":"JM Lee","year":"2012","unstructured":"Lee JM, Yoon CH. Acute coronary stent thrombosis in cancer patients: a case series report. Korean Circ J. 2012;42:487\u201391.","journal-title":"Korean Circ J."},{"key":"286_CR28","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa032691","volume":"350","author":"H Hurwitz","year":"2004","unstructured":"Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plusirinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335\u201342.","journal-title":"N Engl J Med"},{"key":"286_CR29","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1002\/1097-0142(19931001)72:7<2242::AID-CNCR2820720730>3.0.CO;2-E","volume":"72","author":"C Sch\u00f6ber","year":"1993","unstructured":"Sch\u00f6ber C, Papageorgiou E, Harstrick A, et al. Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer. Cancer. 1993;72:2242\u2013727.","journal-title":"Cancer"},{"key":"286_CR30","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ctrv.2011.09.002","volume":"38","author":"A Soultati","year":"2012","unstructured":"Soultati A, Mountzios G, Avgerinou C, et al. Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications. Cancer Treat Rev. 2012;38:473\u201383.","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"286_CR31","doi-asserted-by":"publisher","first-page":"602","DOI":"10.4330\/wjc.v6.i7.602","volume":"6","author":"K Komamura","year":"2014","unstructured":"Komamura K, Fukui M, Iwasaku T, et al. Takotsubo cardiomyopathy: pathophysiology, diagnosis and treatment. World J Cardiol. 2014;6(7):602\u20139.","journal-title":"World J Cardiol."},{"key":"286_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/clc.4960120512","volume":"12","author":"BA Weinberg","year":"1989","unstructured":"Weinberg BA, Conces DJ Jr, Waller BF. Cardiac manifestations of noncardiac tumors. Part I: Direct effects. Clin Cardiol. 1989;12:289\u201396.","journal-title":"Clin Cardiol."},{"key":"286_CR33","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/BF00180313","volume":"70","author":"U Zeymer","year":"1992","unstructured":"Zeymer U, Hirschmann WD, Neuhaus KL. Left main coronary stenosis by a mediastinal lymphoma. Clin Investig. 1992;70:1024\u20136.","journal-title":"Clin Investig."},{"key":"286_CR34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/1874192401408010110","volume":"8","author":"YH Juan","year":"2014","unstructured":"Juan YH, Chatzizisis YS, Saboo SS, Rocha T, Steigner ML. Tumor encasement of the right coronary artery: role of anatomic and functional imaging in diagnosis and therapeutic management. Open Cardiovasc Med J. 2014;8:110\u20132. https:\/\/doi.org\/10.2174\/1874192401408010110 .","journal-title":"Open Cardiovasc Med J."},{"key":"286_CR35","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1200\/JCO.2005.05.827","volume":"23","author":"MS Ewer","year":"2005","unstructured":"Ewer MS, Lippman SM. Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity. J Clin Oncol. 2005;23:2900\u20132. https:\/\/doi.org\/10.1200\/JCO.2005.05.827 .","journal-title":"J Clin Oncol"},{"key":"286_CR36","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00280-005-0178-1","volume":"58","author":"SA Jensen","year":"2006","unstructured":"Jensen SA, S\u00f8rensen JB. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine. Cancer Chemother Pharmacol. 2006;58:487\u201393. https:\/\/doi.org\/10.1007\/s00280-005-0178-1 .","journal-title":"Cancer Chemother Pharmacol"},{"key":"286_CR37","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.mayocp.2015.05.013","volume":"90","author":"J Herrmann","year":"2015","unstructured":"Herrmann J, Bell MR, Warren RL, et al. Complicated and advanced atherosclerosis in a young woman with Philadelphia chromosome-positive acute lymphoblastic leukemia: success and challenges of BCR\/ABL1-targeted cancer therapy. Mayo Clin Proc. 2015;90:1167\u20138. https:\/\/doi.org\/10.1016\/j.mayocp.2015.05.013 .","journal-title":"Mayo Clin Proc"},{"key":"286_CR38","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685\u201395.","journal-title":"N Engl J Med"},{"key":"286_CR39","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1056\/NEJMra052717","volume":"353","author":"C Patrono","year":"2005","unstructured":"Patrono C, Garc\u00eda Rodr\u00edguez LA, Landolfi R, Baigent C. Low dose aspirin for the prevention of atherothrombosis. N Engl J Med. 2005;353:2373\u201383.","journal-title":"N Engl J Med"},{"issue":"27\u201334","key":"286_CR40","first-page":"4","volume":"3","author":"GY Lip","year":"2002","unstructured":"Lip GY, Chin BS, Blann AD. Cancer and the prothrombotic state. Lancet Oncol. 2002;3(27\u201334):4.","journal-title":"Lancet Oncol"},{"key":"286_CR41","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/394740","author":"AD Blann","year":"2011","unstructured":"Blann AD, Dunmore S. Arterial and venous thrombosis in cancer patients. Cardiol Res Pract. 2011. https:\/\/doi.org\/10.4061\/2011\/394740 (article ID 394740).","journal-title":"Cardiol Res Pract."},{"issue":"10","key":"286_CR42","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1007\/s00520-014-2262-8","volume":"22","author":"YN Lin","year":"2014","unstructured":"Lin YN, Chang YJ, Chen YH, et al. Nationwide population-based cohort study on the association of acute coronary syndrome in patients with malignancies. Support Care Cancer. 2014;22(10):2707\u201313.","journal-title":"Support Care Cancer"},{"key":"286_CR43","doi-asserted-by":"crossref","unstructured":"Stavrou EX, Schmaier AH. Venous and arteral thrombosis. Cellular and molecular pathobiology of cardiovascular Disease 2014: 277-296.","DOI":"10.1016\/B978-0-12-405206-2.00015-6"},{"key":"286_CR44","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/ncpcardio1375","volume":"5","author":"IN Daher","year":"2008","unstructured":"Daher IN, Yeh ET. Vascular complications of selected cancer therapies. Nat Clin Pract Cardiovasc Med. 2008;5:797\u2013805.","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"7","key":"286_CR45","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cjca.2015.12.023","volume":"32","author":"AC Cameron","year":"2016","unstructured":"Cameron AC, Touyz RM, Lang NN. Vascular complications of cancer chemotherapy. Can J Cardiol. 2016;32(7):852\u201362. https:\/\/doi.org\/10.1016\/j.cjca.2015.12.023 .","journal-title":"Can J Cardiol"},{"key":"286_CR46","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0735-1097(02)02763-8","volume":"41","author":"CN Bairey Merz","year":"2003","unstructured":"Bairey Merz CN, Johnson BD, Sharaf BL, et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI sponsored WISE study. J Am Coll Cardiol. 2003;41:413\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"286_CR47","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","volume":"109","author":"BM Aleman","year":"2007","unstructured":"Aleman BM, van den Belt-Dusebout AW, De Bruin ML, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood. 2007;109:1878\u201386.","journal-title":"Blood"},{"key":"286_CR48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0002-9343(81)90574-X","volume":"70","author":"FC Brosius","year":"1981","unstructured":"Brosius FC, Waller BF, Roberts WC. Radiation heart disease. Analysis of 16 young (aged 15 to 33\u00a0years) necropsy patients who received over 3500 rads to the heart. Am J Med. 1981;70:519\u201330.","journal-title":"Am J Med"},{"key":"286_CR49","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/1097-0142(19930715)72:2<587::AID-CNCR2820720242>3.0.CO;2-V","volume":"72","author":"F Icli","year":"1993","unstructured":"Icli F, Karaoguz H, Dincol D, et al. Severe vascular toxicity associated with cisplatin-based chemotherapy. Cancer. 1993;72:587\u201393.","journal-title":"Cancer"},{"key":"286_CR50","first-page":"253","volume":"19","author":"BL Samules","year":"1987","unstructured":"Samules BL, Vogelzang NJ, Kennedy BJ. Severe vascular toxicity associated with vinblastine, bleomycin, and cisplatin chemotherapy. Cancer Chemother Pharmacol. 1987;19:253\u20136.","journal-title":"Cancer Chemother Pharmacol"},{"key":"286_CR51","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/blood.V82.7.2261.2261","volume":"82","author":"JY Blay","year":"1993","unstructured":"Blay JY, Favrot M, Rossi JF, Wijdenes J. Role of interleukin-6 in paraneoplastic thrombocytosis. Blood. 1993;82:2261\u20132.","journal-title":"Blood"},{"issue":"1","key":"286_CR52","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4046\/trd.2014.77.1.34","volume":"77","author":"JM Lee","year":"2014","unstructured":"Lee JM, Lim JH, Kim JS, Park JS, Memon A, Lee SK, et al. Multiple hypercoagulability disorders at presentation of non-small cell lung cancer. Tuberc Respir Dis. 2014;77(1):34\u20137.","journal-title":"Tuberc Respir Dis."},{"key":"286_CR53","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/j.athoracsur.2003.12.024","volume":"79","author":"A Borowski","year":"2005","unstructured":"Borowski A, Ghodsizad A, Cohnen M, Gams E. Recurrent embolism in the course of marantic endocarditis. Ann Thorac Surg. 2005;79:2145\u20137.","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"286_CR54","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1055\/s-2003-44641","volume":"29","author":"GF Tempelhoff Von","year":"2003","unstructured":"Von Tempelhoff GF, Heilmann L, Hommel G, Pollow K. Impact of rheological variables in cancer. Semin Thromb Hemost. 2003;29(5):499\u2013513.","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"286_CR55","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1182\/blood.V68.2.514.514","volume":"68","author":"E Fritz","year":"1986","unstructured":"Fritz E, Ludwig H, Scheithauer W, Sinzinger H. Shortened platelet half-life in multiple myeloma. Blood. 1986;68(2):514\u201320.","journal-title":"Blood"},{"issue":"5","key":"286_CR56","first-page":"311","volume":"7","author":"MG Lampugnani","year":"1987","unstructured":"Lampugnani MG, Crawford N. Tumor-cell-induced platelet aggregation: studies with cloned metastatic and nonmetastatic variants. Invasion Metastasis. 1987;7(5):311\u201324.","journal-title":"Invasion Metastasis"},{"issue":"5","key":"286_CR57","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1055\/s-0029-1234144","volume":"35","author":"A Blann","year":"2009","unstructured":"Blann A, Shantsila E, Shantsila A. Microparticles and arterial disease. Semin Thromb Hemost. 2009;35(5):488\u201396.","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"286_CR58","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S0959-8049(02)00596-8","volume":"39","author":"HK Kim","year":"2003","unstructured":"Kim HK, Song KS, Park YS, et al. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer. 2003;39(2):184\u201391.","journal-title":"Eur J Cancer"},{"issue":"4","key":"286_CR59","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1160\/TH07-10-0602","volume":"100","author":"B Toth","year":"2008","unstructured":"Toth B, Liebhardt S, Steinig K, et al. Platelet-derived microparticles and coagulation activation in breast cancer patients. Thromb Haemost. 2008;100(4):663\u20139.","journal-title":"Thromb Haemost"},{"issue":"2","key":"286_CR60","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0169-5002(02)00441-5","volume":"39","author":"S Kanazawa","year":"2003","unstructured":"Kanazawa S, Nomura S, Kuwana M, et al. Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer. Lung Cancer. 2003;39(2):145\u20139.","journal-title":"Lung Cancer"},{"issue":"8","key":"286_CR61","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/ijc.24016","volume":"124","author":"O Dashevsky","year":"2009","unstructured":"Dashevsky O, Varon D, Brill A. Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production. Int J Cancer. 2009;124(8):1773\u20137.","journal-title":"Int J Cancer"},{"issue":"1\u20132","key":"286_CR62","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000093551","volume":"35","author":"FR Rickles","year":"2006","unstructured":"Rickles FR. Mechanisms of cancer-induced thrombosis. Pathophysiol Haemost Thromb. 2006;35(1\u20132):103\u201310.","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"6","key":"286_CR63","first-page":"894","volume":"80","author":"C Shigemori","year":"1998","unstructured":"Shigemori C, Wada H, Matsumoto K, et al. Tissue factor expression and metastatic potential of colorectal cancer. Thromb Haemost. 1998;80(6):894\u20138.","journal-title":"Thromb Haemost"},{"issue":"1","key":"286_CR64","first-page":"9","volume":"9","author":"B \u00d8sterud","year":"1998","unstructured":"\u00d8sterud B. Tissue factor expression by monocytes: regulation and pathophysiological roles. Blood Coag Fibrinol. 1998;9(1):9\u201314.","journal-title":"Blood Coag Fibrinol"},{"issue":"6","key":"286_CR65","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1177\/030089169708300615","volume":"83","author":"D Lucia De","year":"1997","unstructured":"De Lucia D, De Vita F, Orditura M, et al. Hypercoagulable state in patients with advanced gastrointestinal cancer: evidence for an acquired resistance to activated protein C. Tumori. 1997;83(6):948\u201352.","journal-title":"Tumori"},{"issue":"1","key":"286_CR66","first-page":"8","volume":"31","author":"WP Mielicki","year":"2011","unstructured":"Mielicki WP. Biochemistry of cancer procoagulant. Haemostasis. 2011;31(1):8\u201310.","journal-title":"Haemostasis"},{"issue":"1","key":"286_CR67","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/bjc.1993.298","volume":"68","author":"RE Banks","year":"1993","unstructured":"Banks RE, Gearing AJH, Hemingway IK, et al. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer. 1993;68(1):122\u20134.","journal-title":"Br J Cancer"},{"issue":"2","key":"286_CR68","first-page":"117","volume":"21","author":"JWJ Wersch Van","year":"1991","unstructured":"Van Wersch JWJ, Tjwa MKT. Coagulation\/fibrinolysis balance and lung cancer. Haemostasis. 1991;21(2):117\u201323.","journal-title":"Haemostasis"},{"issue":"2","key":"286_CR69","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1365-2141.1995.tb05143.x","volume":"90","author":"AD Blann","year":"1995","unstructured":"Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol. 1995;90(2):244\u20138.","journal-title":"Br J Haematol"},{"issue":"10","key":"286_CR70","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/mc.20663","volume":"49","author":"PL Liu","year":"2010","unstructured":"Liu PL, Tsai JR, Chiu CC, et al. Decreased expression of thrombomodulin is correlated with tumor cell invasiveness and poor prognosis in nonsmall cell lung cancer. Mol Carcinog. 2010;49(10):874\u201381.","journal-title":"Mol Carcinog"},{"key":"286_CR71","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1477-7819-8-85","volume":"8","author":"O Kemik","year":"2010","unstructured":"Kemik O, Sumer A, Kemik AS, et al. The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer. World J Surg Oncol. 2010;8:85.","journal-title":"World J Surg Oncol"},{"issue":"2","key":"286_CR72","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nm0296-209","volume":"2","author":"J Contrino","year":"1996","unstructured":"Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med. 1996;2(2):209\u201315.","journal-title":"Nat Med"},{"issue":"1","key":"286_CR73","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/(SICI)1097-0215(19980220)79:1<19::AID-IJC4>3.0.CO;2-Z","volume":"79","author":"R Koom\u00e4gi","year":"1998","unstructured":"Koom\u00e4gi R, Volm M. Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int J Cancer. 1998;79(1):19\u201322.","journal-title":"Int J Cancer"},{"key":"286_CR74","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/cncr.22434","volume":"109","author":"MG Sarkiss","year":"2007","unstructured":"Sarkiss MG, Yusuf SW, Warneke CL, et al. Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes. Cancer. 2007;109:621\u20137.","journal-title":"Cancer"},{"key":"286_CR75","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1053\/j.seminoncol.2013.01.005","volume":"40","author":"JR Carver","year":"2013","unstructured":"Carver JR, Szalda D, Ky B. Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance. Semin Oncol. 2013;40:229\u201338.","journal-title":"Semin Oncol"},{"issue":"5","key":"286_CR76","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/cncr.2820690528","volume":"69","author":"JF Boivin","year":"1992","unstructured":"Boivin JF, Hutchison GB, Lubin JH, Mauch P. Coronary artery disease mortality in patients treated for Hodgkin\u2019s disease. Cancer. 1992;69(5):1241\u20137.","journal-title":"Cancer"},{"issue":"10","key":"286_CR77","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1161\/CIRCULATIONAHA.116.024811","volume":"135","author":"MM Fidler","year":"2017","unstructured":"Fidler MM, Reulen RC, Henson KE, et al. Population-based long-term cardiac-specific mortality among 34,489 five-year survivors of childhood cancer in Great Britain. Circulation. 2017;135(10):951\u201363. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024811 .","journal-title":"Circulation"},{"issue":"11","key":"286_CR78","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1006\/cyto.1999.0497","volume":"11","author":"A Meeren Van Der","year":"1999","unstructured":"Van Der Meeren A, Squiban C, Gourmelon P, et al. Differential regulation by IL-4 and IL-10 of radiation-induced IL-6 and IL-8 production and ICAM-1 expression by human endothelial cells. Cytokine. 1999;11(11):831\u20138. https:\/\/doi.org\/10.1006\/cyto.1999.0497 .","journal-title":"Cytokine"},{"key":"286_CR79","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcdb.2016.01.045","volume":"58","author":"S Bhattacharya","year":"2016","unstructured":"Bhattacharya S, Asaithamby A. Ionizing radiation and heart risks. Semin Cell Dev Biol. 2016;58:14\u201325. https:\/\/doi.org\/10.1016\/j.semcdb.2016.01.045 .","journal-title":"Semin Cell Dev Biol"},{"issue":"2","key":"286_CR80","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1667\/RR14445.1","volume":"186","author":"Y Wang","year":"2016","unstructured":"Wang Y, Boerma M, Zhou D. Ionizing radiation-induced endothelial cell senescence and cardiovascular diseases. Radiat Res. 2016;186(2):153\u201361.","journal-title":"Radiat Res"},{"key":"286_CR81","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13014-014-0266-7","volume":"9","author":"E Korpela","year":"2014","unstructured":"Korpela E, Liu SK. Endothelial perturbations and therapeutic strategies in normal tissue radiation damage. Radiat Oncol. 2014;9:266. https:\/\/doi.org\/10.1186\/s13014-014-0266-7 .","journal-title":"Radiat Oncol"},{"key":"286_CR82","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fonc.2015.00039","volume":"5","author":"NK Taunk","year":"2015","unstructured":"Taunk NK, Haffty BG, Kostis JB, Goyal S. Radiation-induced heart disease: pathologic abnormalities and putative mechanisms. Front Oncol. 2015;5:39. https:\/\/doi.org\/10.3389\/fonc.2015.00039 .","journal-title":"Front Oncol."},{"issue":"2","key":"286_CR83","doi-asserted-by":"publisher","first-page":"93","DOI":"10.7326\/M15-0424","volume":"164","author":"DA Mulrooney","year":"2016","unstructured":"Mulrooney DA, Armstrong GT, Huang S, et al. Cardiac outcomes in adult survivors of childhood cancer exposed to cardiotoxic therapy: a cross-sectional study. Ann Intern Med. 2016;164(2):93\u2013101. https:\/\/doi.org\/10.7326\/M15-0424 .","journal-title":"Ann Intern Med"},{"issue":"5","key":"286_CR84","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11883-017-0658-x","volume":"19","author":"D Raghunathan","year":"2017","unstructured":"Raghunathan D, Khilji MI, Hassan SA, Yusuf SW. Radiation-induced cardiovascular disease. Curr Atheroscler Rep. 2017;19(5):22. https:\/\/doi.org\/10.1007\/s11883-017-0658-x .","journal-title":"Curr Atheroscler Rep."},{"key":"286_CR85","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ijcard.2015.09.095","volume":"202","author":"J Caro-Codon","year":"2016","unstructured":"Caro-Codon J, Jimenez-Valero S, Galeote G, et al. Radiation-induced coronary artery disease: useful insights from OCT. Int J Cardiol. 2016;202:535\u20136. https:\/\/doi.org\/10.1016\/j.ijcard.2015.09.095 .","journal-title":"Int J Cardiol"},{"issue":"5","key":"286_CR86","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jtcvs.2008.07.005","volume":"136","author":"ML Brown","year":"2008","unstructured":"Brown ML, Schaff HV, Sundt TM. Conduit choices for coronary artery bypass grafting after mediastinal radiation. J Thorac Cardiovasc Surg. 2008;136(5):1167\u201371. https:\/\/doi.org\/10.1016\/j.jtcvs.2008.07.005 .","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"286_CR87","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/annonc\/mdu130","volume":"25","author":"LA Daniels","year":"2014","unstructured":"Daniels LA, Krol AD, de Graaf MA, et al. Screening for coronary artery disease after mediastinal irradiation in Hodgkin lymphoma survivors: phase II study of indication and acceptancedagger. Ann Oncol. 2014;25(6):1198\u2013203.","journal-title":"Ann Oncol"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-018-0286-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-018-0286-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-018-0286-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T04:07:06Z","timestamp":1661486826000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-018-0286-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,22]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["286"],"URL":"https:\/\/doi.org\/10.1007\/s40256-018-0286-z","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,22]]},"assertion":[{"value":"22 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No external funding was used in the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Begum Yetis Sayin and Ali Oto have no conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}